TABLE 1.
Liver parameters in MUL patients undergoing liver biopsy or pericardiectomy (see the text)
| ALT, U/L | AST, U/L | GGT, U/L | Bilirubin, μmol/L | TT, % | APRI | |
|---|---|---|---|---|---|---|
| Biopsy finding | ||||||
| Fibrosis | 40.5 (13–63) a | 40 (22–71) | 59.5 (10–411) | 11 (2–18) | 87.5 (52–118) | 0.4 (0.3–1.2) |
| 5/12 (42) b | 6/10 (60) | 5/10 (50) | 0/9 (0) | 4/12 (33) | 4/9 (44) | |
| Congestion | 26 (17–43) | 60.5 (38–71) | 159 (21–411) | 8 (3–16) | 99 (59–118) | 0.45 (0.3–0.7) |
| 1/5 (20) | 4/4 (100) | 2/3 (66) | 0/5 (0) | 1/5 (20) | 2/4 (50) | |
| Steatosis | 43 (25–58) | 40 (33–71) | 28 (10–159) | 6.5 (2–8) | 90.5 (52–101) | 0.5 (0.3–0.9) |
| 4/8 (50) | 3/7 (42) | 2/7 (29) | 0/4 (0) | 2/8 (25) | 4/7 (57) | |
| Pericardiectomy | ||||||
| Preoperative value | 32 (12–50) | 49.5 (13–84) | 62 (31–411) | 10.5 (8–35) | 62 (46–129) | 0.4 (0.1–1.4) |
| 4/17 (24) | 9/16 (56) | 9/13 (69) | 2/10 (20) | 9/15 (60) | 2/15 (13) | |
| Postoperative value | 27 (11–91) | 39 (23–47) | 55.5 (42–69) | 14 (9–19) | 65 (46–78) | 0.25 (0.1–0.4) |
| 2/7 (29) | 1/6 (17) | 2/2 (100) | 0/2 (0) | 3/4 (75) | 0/4 (0) | |
a
Median value, range.
b
Number of patients with abnormal value/number of patients in the group (percentage).